175 related articles for article (PubMed ID: 22972806)
21. Screening and prevention of breast cancer in primary care.
Tice JA; Kerlikowske K
Prim Care; 2009 Sep; 36(3):533-58. PubMed ID: 19616154
[TBL] [Abstract][Full Text] [Related]
22. Stage distribution of breast cancer diagnosed before and after implementation of population-based mammographic screening.
Hofvind S; Skaane P
Rofo; 2012 May; 184(5):437-42. PubMed ID: 22426937
[TBL] [Abstract][Full Text] [Related]
23. The effect of service screening on breast cancer mortality rates.
Cox B
Eur J Cancer Prev; 2008 Aug; 17(4):306-11. PubMed ID: 18562953
[TBL] [Abstract][Full Text] [Related]
24. Some issues in screening for breast and other cancers.
Duffy SW; McCann J; Godward S; Gabe R; Warwick J
J Med Screen; 2006; 13 Suppl 1():S28-34. PubMed ID: 17227639
[TBL] [Abstract][Full Text] [Related]
25. Screening for breast cancer in England: past and future.
Advisory Committee on Breast Cancer Screening
J Med Screen; 2006; 13(2):59-61. PubMed ID: 16792825
[TBL] [Abstract][Full Text] [Related]
26. Mammographic screening programmes in Europe: organization, coverage and participation.
Giordano L; von Karsa L; Tomatis M; Majek O; de Wolf C; Lancucki L; Hofvind S; Nyström L; Segnan N; Ponti A; ; Van Hal G; Martens P; Májek O; Danes J; von Euler-Chelpin M; Aasmaa A; Anttila A; Becker N; Péntek Z; Budai A; Mádai S; Fitzpatrick P; Mooney T; Zappa M; Ventura L; Scharpantgen A; Hofvind S; Seroczynski P; Morais A; Rodrigues V; Bento MJ; Gomes de Carvalho J; Natal C; Prieto M; Sánchez-Contador Escudero C; Zubizarreta Alberti R; Fernández Llanes SB; Ascunce N; Ederra Sanza M; Sarriugarte Irigoien G; Salas Trejo D; Ibáñez Cabanell J; Wiege M; Ohlsson G; Törnberg S; Korzeniewska M; de Wolf C; Fracheboud J; Patnick J J; Lancucki L; Ducarroz S; Suonio E
J Med Screen; 2012; 19 Suppl 1():72-82. PubMed ID: 22972813
[TBL] [Abstract][Full Text] [Related]
27. Benefit-to-harm ratio of the Danish breast cancer screening programme.
Beau AB; Lynge E; Njor SH; Vejborg I; Lophaven SN
Int J Cancer; 2017 Aug; 141(3):512-518. PubMed ID: 28470685
[TBL] [Abstract][Full Text] [Related]
28. A novel case-control design to estimate the extent of over-diagnosis of breast cancer due to organised population-based mammography screening.
Beckmann KR; Lynch JW; Hiller JE; Farshid G; Houssami N; Duffy SW; Roder DM
Int J Cancer; 2015 Mar; 136(6):1411-21. PubMed ID: 25098753
[TBL] [Abstract][Full Text] [Related]
29. The value of modern mammography screening in the control of breast cancer: understanding the underpinnings of the current debates.
Smith RA
Cancer Epidemiol Biomarkers Prev; 2014 Jul; 23(7):1139-46. PubMed ID: 24991021
[TBL] [Abstract][Full Text] [Related]
30. Breast cancer screening: the evolving evidence.
Smith RA; Duffy SW; Tabár L
Oncology (Williston Park); 2012 May; 26(5):471-5, 479-81, 485-6. PubMed ID: 22730603
[TBL] [Abstract][Full Text] [Related]
31. The benefits and harms of breast cancer screening: an independent review.
Independent UK Panel on Breast Cancer Screening
Lancet; 2012 Nov; 380(9855):1778-86. PubMed ID: 23117178
[TBL] [Abstract][Full Text] [Related]
32. Towards personalized screening: Cumulative risk of breast cancer screening outcomes in women with and without a first-degree relative with a history of breast cancer.
Ripping TM; Hubbard RA; Otten JD; den Heeten GJ; Verbeek AL; Broeders MJ
Int J Cancer; 2016 Apr; 138(7):1619-25. PubMed ID: 26537645
[TBL] [Abstract][Full Text] [Related]
33. [Breast cancer screening in Austria: Key figures, age limits, screening intervals and evidence].
Jeitler K; Semlitsch T; Posch N; Siebenhofer A; Horvath K
Z Evid Fortbild Qual Gesundhwes; 2015; 109(4-5):363-70. PubMed ID: 26354136
[TBL] [Abstract][Full Text] [Related]
34. Risk of breast cancer two years after a benign biopsy depends on the mammographic feature prompting recall.
Vernet-Tomás M; Louro J; Román M; Saladié F; Posso M; Prieto M; Vázquez I; Baré M; Peñalva L; Vidal C; Bargalló X; Sánchez M; Ferrer J; A Espinàs J; Quintana MJ; Rodríguez-Arana A; Castells X;
Maturitas; 2021 Feb; 144():53-59. PubMed ID: 33358209
[TBL] [Abstract][Full Text] [Related]
35. [Evaluation of early detection of breast cancer in Great Britain (author's transl)].
Chamberlain J
Rev Epidemiol Sante Publique; 1981; 29(3):327-34. PubMed ID: 7302314
[TBL] [Abstract][Full Text] [Related]
36. Communicating the balance sheet in breast cancer screening.
Giordano L; Cogo C; Patnick J; Paci E;
J Med Screen; 2012; 19 Suppl 1():67-71. PubMed ID: 22972812
[TBL] [Abstract][Full Text] [Related]
37. The benefits and harms of mammographic screening for breast cancer: building the evidence base using service screening programmes.
Hackshaw A
J Med Screen; 2012; 19 Suppl 1():1-2. PubMed ID: 22972804
[No Abstract] [Full Text] [Related]
38. Absolute numbers of lives saved and overdiagnosis in breast cancer screening, from a randomized trial and from the Breast Screening Programme in England.
Duffy SW; Tabar L; Olsen AH; Vitak B; Allgood PC; Chen TH; Yen AM; Smith RA
J Med Screen; 2010; 17(1):25-30. PubMed ID: 20356942
[TBL] [Abstract][Full Text] [Related]
39. [Breast cancer screening].
Hill C
Presse Med; 2014 May; 43(5):501-9. PubMed ID: 24703730
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
